An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
about
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.The promise of Janus kinase inhibitors in the treatment of hematological malignancies.Humanized mouse models: Application to human diseases.Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy.Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response.A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.Patient-derived Xenografts from Colorectal Carcinoma: A Temporal and Hierarchical Study of Murine Stromal Cell Replacement.Magnetic Resonance Spectroscopy Studies of Mouse Models of Cancer.The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments.Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.Use of patient-derived xenograft mouse models in cancer research and treatment.Murine models based on acute myeloid leukemia-initiating stem cells xenografting.Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathwayTumor xenograft animal models for esophageal squamous cell carcinomaProtocol for the avatar acceptability study: a multiperspective cross-sectional study evaluating the acceptability of using patient-derived xenografts to guide personalised cancer care in Australia and New Zealand
P2860
Q38616707-682A7580-E5BC-4B5C-9927-4FD813B7F43FQ38715093-E6CC6715-1C49-4C9E-BC76-338104AB389AQ39170500-535F5210-2C21-4EC3-98B9-3AE22CDA3255Q39362145-9C498DC1-73A1-4FD4-9D73-8F7720801C43Q41105052-49E1EBEF-37DE-43E6-B6D1-7BFD62388634Q41194627-A483B812-AD86-4F78-848A-0A21D351294CQ41318193-1E5E558B-9FFE-491D-8F3E-A125EC205C7BQ42117987-FA756E18-3A39-4A5E-9A65-EEE000EA5D64Q47145975-759D2DA8-7165-4877-997E-66BB0D249564Q47161111-543ED9C7-E507-4FB9-B9D3-A93ED6D6C653Q47655046-B8F73A50-D153-43AA-BCA8-19C9EC7FC69DQ49284173-B9D6E644-B072-46C0-911C-25A6FE8C7C98Q50185605-476281AE-FC40-411A-9685-D5095970D84FQ50333648-F20C7662-4B80-46C2-89B2-3E495A6019E5Q52671067-C5BE1C42-13B6-4C2D-ABF3-257731F881F2Q53921002-A0953E69-37D1-4BA8-950A-397200A79739Q54983279-38D368F7-1490-4A1D-B2ED-8A92546699F9Q55505569-7E67B572-501D-4AB4-B5D3-9D81DB05C9E6Q57116103-35E6C4B9-FDF1-4B33-94F5-E12248702C9FQ58694943-EA18F8B7-2A39-408D-9FCF-CA8D2FECCB9AQ58795555-343EC316-737A-4BCE-8F71-FC9556179B06
P2860
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@ast
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@en
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@nl
type
label
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@ast
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@en
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@nl
prefLabel
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@ast
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@en
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@nl
P2093
P2860
P921
P1433
P1476
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
@en
P2093
Charles Lee
Hansoo Park
Jee Young Kwon
Jee Yun Han
Jinjoo Kang
Seoyeon Min
Sung-Yup Cho
Wonyoung Kang
P2860
P356
10.14348/MOLCELLS.2016.2350
P407
P577
2016-02-01T00:00:00Z